Standard Operating Procedures in the Disorders of Orgasm and Ejaculation

Journal of Sexual Medicine

Volumn 10, Issue 1, 2013, Pages 204-229

  Mcmahon, Chris G ^a   Jannini, Emmanuele ^b   Waldinger, Marcel ^c   Rowland, David ^d  

^a Australian Centre for Sexual Health   (Australia)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c LEYENBURG HOSPITAL   (Netherlands)

^d VALPARAISO UNIVERSITY   (United States)

Author keywords

Anejaculation; Behavioral Therapy; Delayed Ejaculation; Premature Ejaculation; Retrograde Ejaculation; Selective Serotonin Reuptake Inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; CITALOPRAM; CLOMIPRAMINE; DAPOXETINE; EMLA; FLUOXETINE; KETOCONAZOLE; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PRILOCAINE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TADALAFIL; TEMPE; TERAZOSIN; TESTOSTERONE; THIAZIDE DIURETIC AGENT; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARDENAFIL;

AGITATION; AKATHISIA; ANEJACULATION; ANORGASMIA; ANXIETY; ARTICLE; ATTITUDE TO SEXUALITY; BEHAVIOR THERAPY; CLASSIFICATION ALGORITHM; CLINICAL PRACTICE; COMORBIDITY; CONDITIONING; DELAYED EJACULATION; DEPERSONALIZATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIARRHEA; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; EJACULATION DISORDER; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; FATIGUE; HEADACHE; HEALTH BELIEF; HUMAN; HYPERTHYROIDISM; HYPOACTIVE SEXUAL DESIRE DISORDER; HYPOMANIA; IATROGENIC DISEASE; INSOMNIA; INTRAVAGINAL EJACULATION LATENCY TIME; IRRITABILITY; LABORATORY TEST; MALE; MALE GENITAL SYSTEM FUNCTION; MASTURBATION; MEDICAL HISTORY; MEDICAL SOCIETY; MENTAL CONCENTRATION; NAUSEA; NERVE SURGERY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OFF LABEL DRUG USE; ORGASM DISORDER; PARESTHESIA; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREMATURE EJACULATION; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PSYCHODYNAMICS; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR DOWN REGULATION; RHINOPHARYNGITIS; SELF STIMULATION; SEROTONIN UPTAKE INHIBITOR WITHDRAWAL SYNDROME; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL DYSFUNCTION; SEXUAL EDUCATION; SEXUAL SATISFACTION; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SWEATING; TACHYPHYLAXIS; TOPICAL ANESTHESIA; UNSPECIFIED SIDE EFFECT; UPPER GASTROINTESTINAL BLEEDING; VIVID DREAM; VOMITING; WEIGHT GAIN; WITHDRAWAL SYNDROME; YAWNING;

EID: 84872855333     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02824.x     Document Type: Article

References (231)

1. Yeates W. Ejaculatory disturbances. In: Pryor JP, Lipschultz L, eds. Andrology. Chapt 10, London: Butterworths; 1987:183.
2. McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin ZC. Disorders of orgasm and ejaculation in men. J Sex Med 2004;1:58-65.
3. Peroutka SJ, Snyder SH. Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 1979;16:687-99.
4. Ahlenius SLK, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 1981;15:785-92.
5. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol 2002;168:2359-67.
6. Waldinger MD, Olivier B. Animal models of premature and retarded ejaculation. World J Urol 2005;23:115-8.
7. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJ, Incrocci L, Laan E, Meuleman E, Perelman MA, Rosen RC, Rowland DL, Segraves R. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008;5:1590-606.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM-IV-TR. 4th edition. Revised, Washington, DC: American Psychiatric Association; 2000.
9. World Health Organization. International classification of diseases and related health problems. 10th edition. Geneva: World Health Organization; 1994.
10. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14.
11. McMahon CG, Abdo C, Incrocci I, Perelman M, Rowland D, Waldinger M, Xin ZC. Disorders of orgasm and ejaculation in men. In: Lue TF, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F, eds. Sexual medicine: Sexual dysfunctions in men and women (2nd International Consultation on Sexual Dysfunctions-Paris). Paris, France: Health Publications; J Sex Med 2004:409-68.
12. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID; AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290-4.
13. Metz M, McCarthy B. Coping with premature ejaculation: How to overcome PE, please your partner and have great sex. Oakland, CA: New Harbinber Publications; 2003.
14. Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little Brown; 1970.
15. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med 2005;2:498-507.
16. Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl 2005;28(2 suppl):40-5.
17. Waldinger M, Hengeveld M, Zwinderman A, Olivier B. An empirical operationalization of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract 1998;2:287-93.
18. McMahon CG. Long term results of treatment of premature ejaculation with selective serotonin re-uptake inhibitors. Int J Impot Res 2002;14:S19.
19. Segraves RT. Considerations for an evidence-based definition of premature ejaculation in the DSM-V. J Sex Med 2010;7:672-9.
20. Porst H, McMahon CG, Althof SE, Sharlip I, Bull S, Aquilina JW, Tesfaye F, Rivas DA. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: Integrated analyses of two phase 3 dapoxetine trials. J Sex Med 2010;7:2231-42.
21. Schapiro B. Premature ejaculation, a review of 1, 130 cases. J Urol 1943;50:374-9.
22. Godpodinoff ML. Premature ejaculation: Clinical subgroups and etiology. J Sex Marital Ther 1989;15:130-4.
23. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II-Proposals for DSM-V and ICD-11. J Sex Med 2006;3:693-705.
24. Waldinger MD. The need for a revival of psychoanalytic investigations into premature ejaculation. J Mens Health Gender 2006;3, 4:390-6.
25. Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. J Sex Med 2010;7:810-5.
26. Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, Ekmekcioglu O, Kendirci M, Semerci B, Kadioglu A. The comparison of premature ejaculation assessment questionnaires and their sensitivity for the four premature ejaculation syndromes: Results from the Turkish society of andrology sexual health survey. J Sex Med 2011;8:1177-85.
27. Waldinger M, Quinn P, Dilleen M, Mundayat R, Schweitzer D, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005;2:292-7.
28. Jannini EA, Lenzi A. Epidemiology of premature ejaculation. Curr Opin Urol 2005;15:399-403.
29. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T; GSSAB Investigators' Group. Sexual problems among women and men aged 40-80 years: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57.
30. Nicolosi A, Laumann E, Glaser D, Moreira E, Paik A, Gingell C. Global study of sexual attitudes and behaviors investigator's group. Sexual behavior and sexual dysfunctions after age 40: The global study of sexual attitudes and behaviors. Urology 2004;64:991-7.
31. Montorsi F. Prevalence of premature ejaculation: A global and regional perspective. J Sex Med 2005;2(Suppl 2):96-102.
32. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: Prevalence, comorbidities, and professional help-seeking. Eur Urol 2007;51:816-23.
33. Hyun JS, Kam SC, Kwon OY. Changes of cerebral current source by audiovisual erotic stimuli in premature ejaculation patients. J Sex Med 2008;5:1474-81.
34. Waldinger M, Schweitzer DH. The use of old and recent DSM definitions of premature ejaculation in observational studies: A contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med 2008;5:1079-87.
35. Janssen PK, Bakker SC, Rethelyi J, Zwinderman AH, Touw DJ, Olivier B, Waldinger MD. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med 2009;6:276-84.
36. Jern P, Santtila P, Alanko K, Harlaar N, Johansson A, von der Pahlen B, Varjonen M, Vikström N, Algars M, Sandnabba K. Premature and delayed ejaculation: Genetic and environmental effects in a population-based sample of Finnish twins. J Sex Med 2007;4:1739-49.
37. Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 2001;58:198-202.
38. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005;90:6472-9.
39. Althof SE. Psychological treatment strategies for rapid ejaculation: Rationale, practical aspects, and outcome. World J Urol 2005;1:1.
40. Hartmann U, Schedlowski M, Kruger TH. Cognitive and partner-related factors in rapid ejaculation: Differences between dysfunctional and functional men. World J Urol 2005;10:10.
41. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, Ahn TY. Disorders of orgasm and ejaculation in men. J Sex Med 2010;7:1668-86.
42. Althof S. The psychology of premature ejaculation: Therapies and consequences. J Sex Med 2006;3(4 suppl):324-31.
43. Kaplan HS, Kohl RN, Pomeroy WB, Offit AK, Hogan B. Group treatment of premature ejaculation. Arch Sex Behav 1974;3:443-52.
44. Williams W. Secondary premature ejaculation. Aust N Z J Psychiatry 1984;18:333-40.
45. Dogan S, Dogan M. The frequency of sexual dysfunctions in male partners of women with vaginismus in a Turkish sample. Int J Impot Res 2008;20:218-21.
46. Fasolo CB, Mirone V, Gentile V, Parazzini F, Ricci E. Premature ejaculation: Prevalence and associated conditions in a sample of 12, 558 men attending the andrology prevention week 2001-A Study of the Italian Society of Andrology (SIA). J Sex Med 2005;2:376-82.
47. McMahon CG. Screening for erectile dysfunction in men with lifelong premature ejaculation-Is the Sexual Health Inventory for Men (SHIM) reliable? J Sex Med 2009;6:567-73.
48. Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Chiarini V, Forti G, Maggi M. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med 2008;5:1991-8.
49. Corona G, Mannucci E, Jannini EA, Lotti F, Ricca V, Monami M, Boddi V, Bandini E, Balercia G, Forti G, Maggi M. Hypoprolactinemia: A new clinical syndrome in patients with sexual dysfunction. J Sex Med 2009;6:1457-66.
50. Sadeghi-Nejad H, Watson R. Premature ejaculation: Current medical treatment and new directions (CME). J Sex Med 2008;5:1037-50.
51. Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. J Sex Med 2006;3(4 suppl):309-17.
52. Atkinson RL, Dahms WT, Fisher DA, Nichols AL. Occult thyroid disease in an elderly hospitalized population. J Gerontol 1978;33:372-6.
53. Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med 2006;3(4 suppl):303-8.
54. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Thyroid-stimulating hormone assessments in a Dutch cohort of 620 men with lifelong premature ejaculation without erectile dysfunction. J Sex Med 2005;2:865-70.
55. Zohdy W. Clinical parameters that predict successful outcome in men with premature ejaculation and inflammatory prostatitis. J Sex Med 2009;6:3139-46.
56. Shamloul R, el-Nashaar A. Chronic prostatitis in premature ejaculation: A cohort study in 153 men. J Sex Med 2006;3:150-4.
57. El-Nashaar A, Shamloul R. Antibiotic treatment can delay ejaculation in patients with premature ejaculation and chronic bacterial prostatitis. J Sex Med 2007;4:491-6.
58. Schein M, Zyzanski SJ, Levine S, Medalie JH, Dickman RL, Alemagno SA. The frequency of sexual problems among family practice patients. Fam Pract Res J 1988;7:122-34.
59. Humphrey S, Nazareth I. GP's view on their management of sexual dysfunction. Fam Pract 2001;18:516-8.
60. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger M, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJ, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Tan HM; International Society for Sexual Medicine. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010;7:2947-69.
61. McMahon CG. The etiology and management of premature ejaculation. Nat Clin Pract Urol 2005;2:426-33.
62. Jannini EA, Lenzi A, Wagner G. Behavioural therapy and counselling. In: Schill WB, Comhaire FH, Hargreave TB, eds. Andrology for the clinician. Berlin: Springer; 2006:598-607.
63. Jannini EA, Carosa E, Pepe M, Lombardo F, Lenzi A. Update of pathophysiology of premature ejaculation: The bases for new pharmacological treatments. EAU-EBU Updates 2006; Series 4:141-9.
64. Althof SE. Evidence based assessment of rapid ejaculation. Int J Impot Res 1998;10(2 suppl):S74-6. discussion S7-9.
65. Pryor JL, Broderick GA, Ho KF, Jamieson C, Gagnon D. Comparison of estimated versus measured intravaginal ejaculatory latency time in men with and without premature ejaculation. J Sex Med 2005;3:54.
66. Rosen R, McMahon C, Niederberger C, Broderick G, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: Results from a large observational study of men and their partners. J Urol 2007;177:1059-64.
67. McMahon C. Clinical trial methodology in premature ejaculation observational, interventional and treatment preference studies-Part 1-Defining and selecting the study population. J Sex Med 2008;6:1805-16.
68. Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control and distress associated with premature ejaculation. J Sex Med 2006;3:465-75.
69. Arafa M, Shamloul R. Development and validation of the Arabic Index of Premature Ejaculation (AIPE). J Sex Med 2007;4:1750-6.
70. Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The premature ejaculation profile: Validation of self-reported outcome measures for research and practice. BJU Int 2008;103:358-67.
71. Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L, Crossland A, Morris M, May K. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res 2007;19:521-5.
72. Symonds T, Perelman M, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M. Development and validation of a premature ejaculation diagnostic tool. Eur Urol 2007;52:565-73.
73. Yuan Y, Xin ZC, Jiang J, Guo YJ, Liu WJ, Tian L, Zhu JC. Sexual function of premature ejaculation patients assayed with the Chinese index of premature ejaculation. Asian J Androl 2004;6:121-6.
74. Serefoglu E, Cimen H, Ozdemir A, Symonds T, Berktas M, Balbay M. Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejaculatory latency time. Int J Impot Res 2009;21:139-44.
75. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman M, Jamieson C. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005;2:358-67.
76. Althof S. Sex therapy in the age of pharmacotherapy. Annu Rev Sex Res 2006;17:116-32.
77. Althof S. Treatment of rapid ejaculation: Psychotherapy, pharmacotherapy, and combined therapy. In: Leiblum S, ed. Principles and practice of sex therapy. 4th edition. New York: Guilford Press; 2007:212-41.
78. Perelman M. Sex coaching for physicians: Combination treatment for patient and partner. Int J Impot Res 2003;15:S67-74.
79. Perelman M. A new combination treatment for premature ejaculation. A sex therapist's perspective. J Sex Med 2006;3:1004-12.
80. Donahey K, Miller S. Applying a common factors perspective to sex therapy. J Sex Educ Ther 2000;25:221-30.
81. Mohr D, Bentler L. Erectile dysfunction: A review of diagnostic and treatment procedures. Clin Psychol Rev 1990;10:123-50.
82. Eaton H. Clomipramine in the treatment of premature ejaculation. J Int Med Res 1973;1:432-4.
83. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study. J Urol 1998;159:1935-8.
84. Waldinger M. Towards evidenced based drug treatment research on premature ejaculation: A critical evaluation of methodology. Int J Impot Res 2003;15:309-13.
85. Atmaca M, Kuloglu M, Tezcan E, Semercioz A. The efficacy of citalopram in the treatment of premature ejaculation: A placebo-controlled study. Int J Impot Res 2002;14:502-5.
86. Kara H, Aydin S, Yucel M, Agargun MY, Odabas O, Yilmaz Y. The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo controlled study. J Urol 1996;156:1631-2.
87. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151:1377-9.
88. Goodman RE. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res 1980;8:53-9.
89. Waldinger MD. Drug treatment of premature ejaculation: Pharmacodynamic and pharmacokinetic paradigms. Drug Discovery Today: Therapeutic Strategies 2005;2:37-40.
90. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol 1999;161:1826-30.
91. Strassberg DS, de Gouveia Brazao CA, Rowland DL, Tan P, Slob AK. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther 1999;25:89-101.
92. Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation. Urology 1999;54:544-7.
93. Waldinger MD, Zwinderman AH, Olivier B. On-demand treatment of premature ejaculation with clomipramine and paroxetine: A randomized, double-blind fixed-dose study with stopwatch assessment. Eur Urol 2004;46:510-5.
94. Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: The involvement of the serotonergic system. Behav Brain Res 1998;92:111-8.
95. Sorbera LA, Castaner J, Castaner RM. Dapoxetine hydrochloride. Drugs Future 2004;29:1201-5.
96. Dresser MJ, Lindert K, Lin D. Pharmacokinetics of single and multiple escalating doses of dapoxetine in healthy volunteers. Clin Pharmacol Ther 2004;75:113. (abstract P1).
97. Dresser M, Modi NB, Staehr P, Mulhall JP. The effect of food on the pharmacokinetics of dapoxetine, a new on-demand treatment for premature ejaculation. J Sex Med 2005;3:25. abstract 37.
98. Modi NB, Dresser M, Desai D. Dapoxetine, a new on-demand treatment for premature ejaculation exhibits rapid single and multiple-dose pharmacokinetics. J Sex Med 2006;3:228. abstract P-02-162.
99. Modi NB, Dresser M, Desai D, Edgar C, Wesnes K. Dapoxetine has no pharmacokinetic or cognitive interactions with ethanol in healthy male volunteers. J Clin Pharmacol 2007;47:315-22.
100. Dresser MJ, Kang D, Staehr P, Gidwani S, Guo C, Mulhall JP, Modi NB. Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: Impact of age and effects of a high-fat meal. J Clin Pharmacol 2006;46:1023-9.
101. Dresser MJ, Desai D, Gidwani S, Seftel AD, Modi NB. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res 2006;18:104-10.
102. Modi NB, Dresser MJ, Simon M, Lin D, Desai D, Gupta S. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol 2006;46:301-9.
103. Hellstrom WJ, Gittelman M, Althof S. Dapoxetine HCl for the treatment of premature ejaculation: A Phase II, randomised, double-blind, placebo controlled study. J Sex Med 2004;1(1 suppl):59. abstract 097.
104. Hellstrom WJ, Althof S, Gittelman M, Streidle C, Ho KF, Kell S, Nilson-Beijber A. Dapoxetine for the treatment of men with premature ejaculation (PE): Dose-finding analysis. J Urol 2005;173:238. abstract 877.
105. Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, Miloslavsky M, Kell S; Dapoxetine Study Group. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: An integrated analysis of two double-blind, randomised controlled trials. Lancet 2006;368:929-37.
106. Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009;55:957-67.
107. Kaufman JM, Rosen RC, Mudumbi RV, Tesfaye F, Hashmonay R, Rivas D. Treatment benefit of dapoxetine for premature ejaculation: Results from a placebo-controlled phase III trial. BJU Int 2009;103:651-8.
108. McMahon C, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F, Rothman M, Aquilina J; Dapoxetine 3003 Study Investigators. Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010;7:256-68.
109. Dinsmore WW, Hackett G, Goldmeier D, Waldinger M, Dean J, Wright P, Callander M, Wylie K, Novak C, Keywood C, Heath P, Wyllie M. Topical eutectic mixture for premature ejaculation (TEMPE): A novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int 2007;99:369-75.
110. Henry R, Morales A, Wyllie MG. TEMPE: Topical eutectic-like mixture for premature ejaculation. Expert Opin Drug Deliv 2008;5:251-61.
111. Rowland D, Perelman M, Althof S, Barada J, McCullough A, Bull S, Jamieson C, Ho KF. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004;1:225-32.
112. Rowland DL, Cooper SE, Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav 2001;30:235-53.
113. Rowland DL, Tai WL, Slob AK. An exploration of emotional response to erotic stimulation in men with premature ejaculation: Effects of treatment with clomipramine. Arch Sex Behav 2003;32:145-53.
114. Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man's life? J Sex Marital Ther 2003;29:361-70.
115. Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: How are they related? Br J Psychiatry 1988;152:629-31.
116. Sotomayor M. The burden of premature ejaculation: The patient's perspective. J Sex Med 2005;2(2 suppl):110-4.
117. Damrav E. Premature ejaculation: Use of ethyl amino benzoate to prolong coitus. J Urol 1963;89:936-9.
118. Pasini W. Sexologic problems in dermatology. Clin Dermatol 1984;2:59-65.
119. Kaplan HS. PE: How to overcome premature ejaculation. New York: Brunner/Mazel; 1989.
120. Kaplan H. The evaluation of sexual disorders: The urologic evaluation of ejaculatory disorders. New York: Brunner/Mazel; 1983.
121. Levine S. Helping men to control ejaculation. In: Levine S, ed. Sexual life: A clinician's guide. New York: Plenum Press; 1992:90-106.
122. de Carufel F, Trudel G. Effects of a new functional-sexological treatment for premature ejaculation. J Sex Marital Ther 2006;32:97-114.
123. Golden JS, Price S, Heinrich AG, Lobitz WC. Group vs. couple treatment of sexual dysfunctions. Arch Sex Behav 1978;7:593-602.
124. Hawton K, Catalan J, Martin P, Fagg J. Long-term outcome of sex therapy. Behav Res Ther 1986;24:665-75.
125. De Amicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Three-year follow-up of couples evaluated for sexual dysfunction. J Sex Marital Ther 1984;10:215-28.
126. Althof SE, Wieder M. Psychotherapy for erectile dysfunction: Now more relevant than ever. Endocrine 2004;23:131-4.
127. Althof S. Therapeutic weaving: The integration of treatment techniques. In: Levine S, Risen C, Althof S, eds. Handbook of clinical sexuality for mental health professionals. New York: Bruner-Routledge; 2003:359-76.
128. Levine S. Sexual life, a clinician's guide. New York: Plenum; 1992.
129. McCarthy B. Cognitive-behavioral strategies and techniques in the treatment of early ejaculation. In: Leiblum SR, Rosen RC, eds. Principles and practice of sex therapy: Update for the 90s. New York: Guilford Press; 1990:141-67.
130. Zilbergeld B. The new male sexuality. New York: Bantam; 1992.
131. Lowe JC, Mikulas WL. Use of written material in learning self-control of premature ejaculation. Psychol Rep 1975;37:295-8.
132. Zeiss RA, Christensen A, Levine AG. Treatment for premature ejaculation through male-only groups. J Sex Marital Ther 1978;4:139-43.
133. Trudel G, Proulx S. Treatment of premature ejaculation by bibliotherapy: An experimental study. Sex Marital Ther 1987;2:163-7.
134. Verhulst J, Heiman J. A systems perspective on sexual desire. In: Lieblum S, Rosen R, eds. Sexual desire disorders. New York: Guilford; 1988:243-67.
135. Wincze JP, Carey MP. Sexual dysfunction: A guide for assessment and treatment. New York: Guilford; 1991.
136. Hawton K. Integration of treatments for male erectile dysfunction. Lancet 1998;351:7-8.
137. Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 1997;8:148-94.
138. Waldinger MD. Premature ejaculation: Definition and drug treatment. Drugs 2007;67:547-68.
139. Marangell LB, Dennehy EB, Wisniewski SR, Bauer MS, Miyahara S, Allen MH, Martinez M, Al Jurdi RK, Thase ME. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: Findings from STEP-BD. J Clin Psychiatry 2008;69:916-22.
140. Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D, Wagner KD. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 2006;31:473-92.
141. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. Am J Psychiatry 2003;160:790-2.
142. Ditto KE. SSRI discontinuation syndrome. Awareness as an approach to prevention. Postgrad Med 2003;114:79-84.
143. Black K, Shea CA, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria. J Psychiatry Neurosci 2000;25:255-61.
144. Li N, Wallen NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997;8:517-23.
145. Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005;4:337-44.
146. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
147. Ahmad S. Paroxetine-induced priapism. Arch Intern Med 1995;155:645.
148. Rand EH. Priapism in a patient taking sertraline. J Clin Psychiatry 1998;59:538.
149. Dent LA, Brown WC, Murney JD. Citalopram-induced priapism. Pharmacotherapy 2002;22:538-41.
150. Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC. Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment. J Clin Psychiatry 2000;61:863-7.
151. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1, 022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001;62:10-21.
152. Lane RM. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J Psychopharmacol 1997;11:72-82.
153. Berkovitch M, Keresteci AG, Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol 1995;154:1360-1.
154. Xin ZC, Choi YD, Lee SH, Choi HK. Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: Preliminary clinical studies. Yonsei Med J 1997;38:91-5.
155. Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: A double-blind, randomized, placebo-controlled study. BJU Int 2004;93:1018-21.
156. Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, Bull S. Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation. J Sex Med 2010;7:2243-52.
157. Cavallini G. Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. Eur Urol 1995;28:126-30.
158. Basar MM, Yilmaz E, Ferhat M, Basar H, Batislam E. Terazosin in the treatment of premature ejaculation: A short-term follow-up. Int Urol Nephrol 2005;37:773-7.
159. Frink MC, Hennies HH, Englberger W, Haurand M, Wilffert B. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung 1996;46:1029-36.
160. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA. Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med 2008;5:188-93.
161. Alghobary M, El-Bayoumy Y, Mostafa Y, Mahmoud el HM, Amr M. Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. J Sex Med 2010;7:2860-7.
162. Bar-Or D, Salottolo KM, Orlando A, Winkler JV. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol 2012;61:736-43.
163. Fein RL. Intracavernous medication for treatment of premature ejaculation. Urology 1990;35:301-3.
164. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001;13:41-5.
165. Chia S. Management of premature ejaculation-A comparison of treatment outcome in patients with and without erectile dysfunction. Int J Androl 2002;25:301-5.
166. Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486-9.
167. Erenpreiss J, Zalkalns J. Premature ejaculation: Comparison of patroxetine alone, paroxetine plus local lidocaine and paroxetine plus sildenafil. Int J 2002;14:S33. abstract PS-7-4.
168. Linn R, Ginesin Y, Hardak S, Mertyk S. Treatment of sildenafil as part of the treatment in premature ejaculation. Int J 2002;14:S39. abstract P-168.
169. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197-200.
170. Li X, Zhang SX, Cheng HM, Zhang WD. Clinical study of sildenafil in the treatment of premature ejaculation complicated by erectile dysfunction. Zhonghua Nan Ke Xue 2003;9:266-9.
171. Lozano AF. Premature ejaculation pharmacological treatment three years after. Int J Impot Res 2003;15:S11. abstract MP-2-6.
172. Tang W, Ma L, Zhao L, Liu Y, Chen Z. Clinical efficacy of Viagra with behavior therapy against premature ejaculation. Zhonghua Nan Ke Xue 2004;10:366-7.
173. Zhang XS, Wang YX, Huang XY, Leng J, Li Z, Han YF. Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation. Zhonghua Nan Ke Xue 2005;11:520-2.
174. McMahon CG, Stuckey B, Andersen ML. Efficacy of Viagra: Sildenafil citrate in men with premature ejaculation. J Sex Med 2005;2:368-75.
175. Sommer F, Klotz T, Mathers MJ. Treatment of premature ejaculation: A comparative vardenafil and SSRI crossover study. J Urol 2005;173:202. abstract 741.
176. Mattos RM, Lucon AM. Tadalafil and slow-release fluoxetine in premature ejaculation-A prospective study. J Urol 2005;173:239.
177. Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 2006;67:388-91.
178. Sun XZ, Deng CH, Dai YP. A clinical study of sertralin and vardenafil in the treatment of premature ejaculation complicated by erectile dysfunction. Zhonghua Nan Ke Xue 2007;13:610-2.
179. Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008;80:162-5.
180. Aversa A, Pili M, Francomano D, Bruzziches R, Spera E, La Pera G, Spera G. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res 2009;21:221-7.
181. Mathers MJ, Klotz T, Roth S, Lummen G, Sommer F. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study. Andrologia 2009;41:169-75.
182. Jannini EA, McMahon C, Chen J, Aversa A, Perelman M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med 2011;8:2135-43.
183. Mamas MA, Reynard JM, Brading AF. Nitric oxide and the lower urinary tract: Current concepts, future prospects. Urology 2003;61:1079-85.
184. McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review. BJU Int 2006;98:259-72.
185. Kim JJ, Kwak TI, Jeon BG, Cheon J, Moon DG. Effects of glans penis augmentation using hyaluronic acid gel for premature ejaculation. Int J Impot Res 2004;16:547-51.
186. Shi WG, Wang XJ, Liang XQ, Liu ZQ, Huang MJ, Li SQ, Ren SQ, Cao L, Meng X, Wang Z, Chen RS. Selective resection of the branches of the two dorsal penile nerves for primary premature ejaculation. Zhonghua Nan Ke Xue 2008;14:436-8.
187. Kwak TI, Jin MH, Kim JJ, Moon DG. Long-term effects of glans penis augmentation using injectable hyaluronic acid gel for premature ejaculation. Int J Impot Res 2008;20:425-8.
188. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005;2:492-7.
189. Segraves RT. Considerations for a better definition of male orgasmic disorder in DSM V. J Sex Med 2010;7:690-5.
190. Perelman M. Retarded ejaculation. Curr Sex Health Rep 2004;1:95-101.
191. Comarr AE. Sexual function among patients with spinal cord injury. Urol Int 1970;25:134-68.
192. Kaplan HS. The new sex therapy. New York: Brunner/Mazel; 1974.
193. Waldinger MD, Schweitzer DH. Retarded ejaculation in men: An overview of psychological and neurobiological insights. World J Urol 2005;4:4.
194. Munjack DJ, Kanno PH. Retarded ejaculation: A review. Arch Sex Behav 1979;8:139-50.
195. Shull GR, Sprenkle DH. Retarded ejaculation reconceptualization and implications for treatment. J Sex Marital Ther 1980;6:234-46.
196. Perelman MA, Rowland DL. Retarded ejaculation. World J Urol 2006;24:645-52.
197. Perelman MA. Integrating sildenafil and sex therapy: Unconsummated marriage secondary to ED and RE. J Sex Educ Ther 2001;26:13-21.
198. Perelman MA. FSD partner issues: Expanding sex therapy with sildenafil. J Sex Marital Ther 2002;28:195-204.
199. Perelman M. Idiosyncratic masturbation patterns: A key unexplored variable in the treatment of retarded ejaculation by the practicing urologist. J Urol 2005;173:340.
200. Perelman MA. Masturbation is a key variable in the treatment of retarded ejaculation by health care practitioners [abstract #120]. J Sex Med 2006;3:51-2.
201. Perelman MA. Unveiling retarded ejaculation [abstract #1337]. J Urol 2006;175:430.
202. Perelman MA. Masturbation revisited. Contemp Urol 1994;6:68-70.
203. Hendry WF, Althof SE, Benson GS, Haensel SM, Hull EM, Kihara K, Opsomer RJ. Male orgasmic and ejaculatory disorders. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R, eds. Erectile dysfunction. Paris, France: Health Publication, Ltd. Distributed by Plymbridge, Plymouth UK; 2000:477-506.
204. Waldinger M. Use of psychoactive agents in the treatment of sexual dysfunction. CNS Drugs 1996;6:204-16.
205. Drach GW, Fair WR, Meares EM, Stamey TA. Classification of benign diseases associated with prostatic pain: Prostatitis or prostatodynia? J Urol 1978;120:266.
206. Schlegel PN, Shin D, Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 1996;155:1644-8.
207. Mickle J, Milunsky A, Amos JA, Oates RD. Congenital unilateral absence of the vas deferens: A heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene. Hum Reprod 1995;10:1728-35.
208. Apfelbaum B. Retarded ejaculation: A much-misunderstood syndrome. In: Lieblum SR, Rosen RC, eds. Principles and practice of sex therapy: Update for the 1990's. 2nd edition. New York: Guilford Press; 1989:168-206.
209. McCarthy B. Strategies and techniques for the treatment of ejaculatory inhibition. J Sex Educ Ther 1981;7:20-3.
210. McMahon CG, Waldinger M, Rowland DL, Assalian P, Chan Kim Y, Bechara A, Riley A. Ejaculatory disorders. In: Porst H, Buvat J, eds. Standard practice in sexual medicine. Oxford UK: Blackwell Publishing; 2006:188-209.
211. Kaplan H. The evaluation of sexual disorders: Psychological and medical aspects. New York: Brunner/Mazel; 1995.
212. Barbach LG. For yourself: A guide to female orgasmic response. New York: Doubleday; 1974.
213. Hendry WF. Disorders of ejaculation: Congenital, acquired and functional. Br J Urol 1998;82:331-41.
214. Delmonte M. Meditation as a clinical intervention strategy: A brief review. Int J Psychosom 1986;33:9-12.
215. Fisher W. Multimodal sex therapy with a blind man suffering from retarded ejaculation. Special issue: Social work practice in sexual problems. J Soc Work Hum Sex 1986;4:95-107.
216. Pettitt G. Retarded ejaculation: Adjunctive treatment by hypnotically induced dreams in the context of sex therapy. Aust J Clin Exp Hypn 1982;10:89-98.
217. Zgourides GWR. Retarded ejaculation: Overview and treatment implications. J Psychol Human Sex 1990;2:139-50.
218. Ohl D, Menge AC, Sonksen J. Penile vibratory stimulation in spinal cord injured men: Optimized vibration parameters and prognostic factors. Arch Phys Med Rehabil 1996;77:903.
219. McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry 1990;51:383-4.
220. Ashton K, Hamer R, Rosen R. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997;23:165-75.
221. Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry 1991;52:163-4.
222. Lauerma H. Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand 1996;93:69-70.
223. Cohen A. Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment. J Clin Psychiatry 1992;53:174.
224. Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1995;18:320-4.
225. Ferraz MR, Santos R. Amantadine stimulates sexual behavior in male rats. Pharmacol Biochem Behav 1995;51:709-14.
226. Yells DP, Prendergast MA, Hendricks SE, Miller ME. Monoaminergic influences on temporal patterning of sexual behavior in male rats. Physiol Behav 1995;58:847-52.
227. Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther 1996;22:290-2.
228. Shrivastava R, Shrivastava S, Overweg N, Schmitt M. Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1995;15:83-4.
229. Gitlin MJ. Treatment of sexual side effects with dopaminergic agents. J Clin Psychiatry 1995;56:124.
230. Valevski A, Modai I, Zbarski E, Zemishlany Z, Weizman A. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients. Clin Neuropharmacol 1998;21:355-7.
231. Balogh S, Hendricks S, Kang J. Treatment of fluoxetine-induced anorgasmia with amantadine. J Clin Psychiatry 1992;53:212-3.